Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial

作者：Lei Fan, Wenjuan Zhang, Huiping Li, Xiaohua Zeng, Yue-E Teng, Yue Gong, Xi Jin, Shen Zhao, Tao Sun, Wenyan Chen, Shu-Sen Wang, Jin Yang, Zhigang Zhuang, Sujie Ni, Zhixian He, Deyuan Fu, Chuangui Song, Zheng Lv, Qian-Nan Liang, Bao-Hua Yu, Jing Shi, Nan Wang, Xin-Rui Liang, Ningning Zhang, Yun Wang, Peng Ji, Xiyu Liu, Li Chen, Min He, Yin Liu, Xin-Yi Sui, Linxiaoxi Ma, Xiu-Zhi Zhu, Fan Yang, Li‐Ping Ge, Songyang Wu, Jiong Wu, Ke‐Da Yu, Guang‐Yu Liu, Xin Hu, Yu Shen, Zheng Pang, Jianfei Wang, Fei Liang, Wentao Yang, Zhonghua Wang, Yi-Zhou Jiang, Zhi-Ming Shao · 发表于：Cancer Cell · 年份：2025 · DOI：10.1016/j.ccell.2025.11.003 · 被引用次数：4 · 研究领域：Advanced Breast Cancer Therapies、HER2/EGFR in Cancer Research、Breast Cancer Treatment Studies